Measles historical perspective
|
Measles Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Measles historical perspective On the Web |
|
American Roentgen Ray Society Images of Measles historical perspective |
|
Risk calculators and risk factors for Measles historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview====Overview
The measles virus was isolated in cell culture in 1954, by Jhon F. Enders and Thomas C. Peebles. This was the first step that allowed the development of a successful vaccine, licensed 9 years later, in 1963. To date, 21 strains of the measles virus have been identified.[1]
Discovery
Reports of measles go as far back to at least 600 B.C. however, the first scientific description of the disease and its distinction from smallpox is attributed to the Persian physician Ibn Razi (Rhazes) 860-932 who published a book entitled "Smallpox and Measles" (in Arabic: Kitab fi al-jadari wa-al-hasbah). One of the earliest written descriptions of measles as a disease was provided by an Arab physician in the 9th century who described differences between measles and smallpox in his medical notes. A Scottish physician, Francis Home, demonstrated in 1757 that measles was caused by an infectious agent present in the blood of patients. In 1954 the virus that causes measles was isolated from an 11-year old boy from the US, David Edmonston, and adapted and propagated on chick embryo tissue culture in Boston, Massachusetts, by John F. Enders and Thomas C. Peebles. .
Development of treatment strategies
- Before measles vaccine, nearly all children got measles by the time they were 15 years of age. Each year in the United States about 450-500 people died because of measles, 48,000 were hospitalized, 7,000 had seizures, and about 1,000 suffered permanent brain damage or deafness. Today there are only about 60 cases a year reported in the United States, and most of these originate outside the country.
- The first measles vaccines were licensed in 1963. In that year, both an inactivated (“killed”) and a live attenuated vaccine (Edmonston B strain) were licensed for use in the United States.
- The inactivated vaccine was withdrawn in 1967 because it did not protect against measles virus infection. Furthermore, recipients of inactivated measles vaccine frequently developed a unique syndrome, atypical measles, if they were infected with wild-type measles virus.
- The original Edmonston B vaccine was withdrawn in 1975 because of a relatively high frequency of fever and rash in recipients.
- A live, further attenuated vaccine (Schwarz strain) was first introduced in 1965 but also is no longer used in the United States.
- Another live, further attenuated strain vaccine (Edmonston-Enders strain) was licensed in 1968. These further attenuated vaccines caused fewer reactions than the original Edmonston B vaccine.
- The only measles virus vaccine now available in the United States is a live, more attenuated Edmonston-Enders strain (formerly called “Moraten”). The vaccine is available combined with mumps and rubella vaccines as MMR, or combined with mumps, rubella, and varicella vaccine as MMRV (ProQuad). Single-antigen measles vaccine is not currently available in the United States.
- Measles vaccine is prepared in chick embryo fibroblast tissue culture. MMR and MMRV are supplied as a lyophylized (freeze-dried) powder and are reconstituted with sterile, preservative-free water. The vaccines contain a small amount of human albumin, neomycin, sorbitol, and gelatin.
References
- ↑ Rima BK, Earle JA, Yeo RP, Herlihy L, Baczko K, ter Muelen V, Carabana J, Caballero M, Celma ML, Fernandez-Munoz R 1995 Temporal and geographical distribution of measles virus genotypes. J Gen Virol 76:11731180.